REQUEST A DEMO
Total
USD $0.00
Search more companies

Saneca Pharmaceuticals A. S. (Slovakia)

Main Activities: Pharmaceutical and Medicine Manufacturing | Pharmaceutical Preparation Manufacturing
Full name: Saneca Pharmaceuticals A. S. Profile Updated: July 31, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Saneca Pharmaceuticals A.S. is a Slovak contract development and manufacturing organization (CDMO) operating a multi-purpose pharmaceutical production and development site in Hlohovec, Slovakia. The company specializes in synthesis of active pharmaceutical ingredients (APIs), including controlled substances and complex synthetic APIs, and in the formulation and manufacture of finished dosage forms - primarily oral solid dosage forms such as tablets, capsules and pellets. Saneca offers contract development and manufacturing services to pharmaceutical companies, including early-phase API development (small-scale labs), scale-up to commercial production, analytical services and logistics. Its assets include a vertically integrated manufacturing campus, regulatory and quality-management capabilities, and experience in both generic and custom product development. Geographically, it serves an international customer base across Europe and beyond, using its Slovak site as a cost-effective but technically capable production hub. Strategically, Saneca positions itself as a flexible, reliable CDMO partner, offering quality-driven services, regulatory expertise, cost-efficient production and full-service support across the development and manufacturing lifecycle - enabling clients to bring pharmaceutical products to market efficiently.

Headquarters
Nitrianska, 100
Hlohovec; Trnavsky; Postal Code: 92027

Contact Details: Purchase the Saneca Pharmaceuticals A. S. report to view the information.

Website: http://www.saneca.com/sk/

Basic Information
Total Employees:
Purchase the Saneca Pharmaceuticals A. S. report to view the information.
Registered Capital:
Purchase the Saneca Pharmaceuticals A. S. report to view the information.
Financial Auditors:
Purchase the Saneca Pharmaceuticals A. S. report to view the information.
Incorporation Date:
September 19, 2012
Key Executives
Purchase this report to view the information.
Chairman of the Board
Purchase this report to view the information.
Vice-chair of the Board
Purchase this report to view the information.
Vice-chair of the Board
Purchase this report to view the information.
Member of the Supervisory Board
Purchase this report to view the information.
Member of the Supervisory Board
Company Performance
Financial values in the chart are available after Saneca Pharmaceuticals A. S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
9.92%
Total operating revenue
11.21%
Operating profit (EBIT)
41.86%
EBITDA
33.03%
Net Profit (Loss) for the Period
30.78%
Total Assets
9.42%
Total Equity
29.94%
Operating Profit Margin (ROS)
3.09%
Net Profit Margin
1.67%
Return on Equity (ROE)
0.13%
Debt/Equity
-18.26%
Quick Ratio
-0.24%
Cash Ratio
-0.05%

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?